Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 9 | 2024 | 506 | 3.540 |
Why?
|
| Monitoring, Intraoperative | 3 | 2024 | 114 | 1.440 |
Why?
|
| Echocardiography, Transesophageal | 6 | 2024 | 262 | 1.430 |
Why?
|
| Analgesia | 2 | 2022 | 64 | 1.390 |
Why?
|
| Myocardial Infarction | 3 | 2018 | 383 | 1.120 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 339 | 1.090 |
Why?
|
| Postoperative Complications | 7 | 2024 | 2562 | 1.000 |
Why?
|
| Hypotension | 2 | 2017 | 72 | 0.870 |
Why?
|
| Vascular Resistance | 1 | 2024 | 97 | 0.860 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 375 | 0.790 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2024 | 217 | 0.780 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2022 | 283 | 0.760 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2022 | 13 | 0.760 |
Why?
|
| Coronary Artery Bypass | 3 | 2022 | 224 | 0.750 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 151 | 0.720 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 100 | 0.710 |
Why?
|
| Kidney Diseases | 2 | 2022 | 315 | 0.680 |
Why?
|
| Morphine | 1 | 2021 | 128 | 0.660 |
Why?
|
| Tissue Donors | 1 | 2024 | 541 | 0.640 |
Why?
|
| Medicine | 1 | 2021 | 95 | 0.620 |
Why?
|
| Kidney | 1 | 2024 | 1111 | 0.610 |
Why?
|
| Hospital Rapid Response Team | 1 | 2019 | 28 | 0.600 |
Why?
|
| Robotic Surgical Procedures | 2 | 2022 | 368 | 0.600 |
Why?
|
| Tissue and Organ Procurement | 1 | 2024 | 388 | 0.590 |
Why?
|
| Mitral Valve | 4 | 2021 | 225 | 0.590 |
Why?
|
| Marriage | 1 | 2019 | 24 | 0.580 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 1 | 2019 | 42 | 0.550 |
Why?
|
| Wireless Technology | 1 | 2018 | 21 | 0.540 |
Why?
|
| Heart Transplantation | 1 | 2024 | 811 | 0.540 |
Why?
|
| Humans | 36 | 2024 | 93515 | 0.530 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 148 | 0.530 |
Why?
|
| Cystectomy | 1 | 2018 | 113 | 0.520 |
Why?
|
| Myocardium | 2 | 2022 | 570 | 0.510 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2018 | 95 | 0.510 |
Why?
|
| Heart-Assist Devices | 4 | 2022 | 882 | 0.510 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2017 | 21 | 0.510 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 513 | 0.500 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1194 | 0.460 |
Why?
|
| Mitochondria | 1 | 2019 | 612 | 0.450 |
Why?
|
| Endoscopy | 2 | 2022 | 366 | 0.420 |
Why?
|
| Aortic Valve | 4 | 2022 | 250 | 0.410 |
Why?
|
| Angiotensins | 1 | 2013 | 5 | 0.400 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 394 | 0.390 |
Why?
|
| Graft Rejection | 1 | 2018 | 1120 | 0.380 |
Why?
|
| Heparin | 1 | 2013 | 181 | 0.370 |
Why?
|
| Lung Transplantation | 1 | 2017 | 367 | 0.360 |
Why?
|
| Elective Surgical Procedures | 1 | 2013 | 163 | 0.350 |
Why?
|
| Preoperative Care | 1 | 2013 | 406 | 0.330 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 107 | 0.320 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2011 | 116 | 0.320 |
Why?
|
| Robotics | 1 | 2011 | 269 | 0.290 |
Why?
|
| Prospective Studies | 4 | 2024 | 4560 | 0.270 |
Why?
|
| Creatinine | 2 | 2022 | 293 | 0.260 |
Why?
|
| Middle Aged | 12 | 2024 | 27573 | 0.260 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2013 | 176 | 0.250 |
Why?
|
| Treatment Outcome | 4 | 2022 | 9099 | 0.240 |
Why?
|
| Aged | 8 | 2024 | 20434 | 0.230 |
Why?
|
| Blood Transfusion | 2 | 2019 | 175 | 0.210 |
Why?
|
| Death | 1 | 2024 | 97 | 0.200 |
Why?
|
| Female | 10 | 2024 | 48702 | 0.190 |
Why?
|
| Organ Preservation | 1 | 2024 | 130 | 0.190 |
Why?
|
| Brain Death | 1 | 2024 | 88 | 0.190 |
Why?
|
| Morphine Derivatives | 1 | 2022 | 8 | 0.190 |
Why?
|
| Male | 13 | 2024 | 44557 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2024 | 756 | 0.180 |
Why?
|
| Heart Arrest, Induced | 1 | 2022 | 30 | 0.180 |
Why?
|
| Portal Vein | 1 | 2022 | 119 | 0.180 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 7061 | 0.180 |
Why?
|
| Injections, Spinal | 1 | 2021 | 48 | 0.180 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2012 | 187 | 0.180 |
Why?
|
| Length of Stay | 2 | 2018 | 828 | 0.170 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 379 | 0.170 |
Why?
|
| Aorta | 1 | 2022 | 273 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 1229 | 0.170 |
Why?
|
| Pulmonary Edema | 1 | 2021 | 53 | 0.160 |
Why?
|
| Myxoma | 1 | 2020 | 28 | 0.160 |
Why?
|
| Embolism | 1 | 2020 | 32 | 0.160 |
Why?
|
| Stroke Volume | 1 | 2022 | 438 | 0.160 |
Why?
|
| Arachnodactyly | 1 | 2020 | 2 | 0.160 |
Why?
|
| DiGeorge Syndrome | 1 | 2020 | 11 | 0.160 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 29 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 52 | 0.160 |
Why?
|
| Biomarkers | 2 | 2019 | 1910 | 0.150 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1729 | 0.150 |
Why?
|
| Craniosynostoses | 1 | 2020 | 71 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2022 | 219 | 0.150 |
Why?
|
| Glycation End Products, Advanced | 1 | 2018 | 12 | 0.140 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2018 | 20 | 0.140 |
Why?
|
| Retrospective Studies | 2 | 2024 | 10164 | 0.140 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2018 | 24 | 0.140 |
Why?
|
| Echocardiography | 1 | 2022 | 745 | 0.140 |
Why?
|
| Risk Factors | 3 | 2022 | 5899 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 204 | 0.140 |
Why?
|
| Spleen | 1 | 2018 | 374 | 0.130 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2018 | 45 | 0.130 |
Why?
|
| Electroencephalography | 1 | 2022 | 797 | 0.130 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2018 | 92 | 0.130 |
Why?
|
| Electric Stimulation | 1 | 2018 | 344 | 0.130 |
Why?
|
| Heart Failure, Diastolic | 1 | 2016 | 2 | 0.130 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 367 | 0.120 |
Why?
|
| Ventricular Function, Left | 2 | 2018 | 520 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 225 | 0.120 |
Why?
|
| Ambulatory Care | 1 | 2018 | 193 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2018 | 257 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2018 | 283 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 624 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2016 | 188 | 0.110 |
Why?
|
| Hypoxia | 1 | 2018 | 675 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2018 | 650 | 0.100 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 49 | 0.100 |
Why?
|
| Inflammation | 1 | 2019 | 1050 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 96 | 0.100 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2013 | 128 | 0.090 |
Why?
|
| Respiration, Artificial | 2 | 2011 | 423 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 59 | 0.090 |
Why?
|
| Cysteine | 1 | 2012 | 145 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2012 | 139 | 0.080 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 85 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 98 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 356 | 0.080 |
Why?
|
| Hypertension | 1 | 2016 | 757 | 0.080 |
Why?
|
| Coronary Vessels | 1 | 2012 | 178 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 1 | 2011 | 147 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2012 | 379 | 0.080 |
Why?
|
| Adult | 4 | 2013 | 27918 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 467 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2011 | 482 | 0.070 |
Why?
|
| Acute Disease | 1 | 2011 | 841 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2011 | 350 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2011 | 713 | 0.070 |
Why?
|
| Logistic Models | 1 | 2011 | 1243 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2018 | 3502 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2011 | 454 | 0.070 |
Why?
|
| Chicago | 1 | 2011 | 1464 | 0.060 |
Why?
|
| Insulin | 1 | 2012 | 1185 | 0.060 |
Why?
|
| Mice | 1 | 2018 | 12269 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2011 | 2441 | 0.050 |
Why?
|
| Pregnancy | 1 | 2011 | 3147 | 0.050 |
Why?
|
| Time Factors | 1 | 2011 | 5410 | 0.050 |
Why?
|
| Stroke | 1 | 2011 | 1079 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2022 | 76 | 0.050 |
Why?
|
| Young Adult | 1 | 2013 | 6930 | 0.040 |
Why?
|
| Animals | 1 | 2018 | 28155 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 149 | 0.040 |
Why?
|
| Heart Atria | 1 | 2020 | 248 | 0.040 |
Why?
|
| Counterpulsation | 1 | 2018 | 21 | 0.030 |
Why?
|
| Reoperation | 1 | 2020 | 702 | 0.030 |
Why?
|
| Vitrectomy | 1 | 2016 | 48 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 3054 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2013 | 129 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 135 | 0.020 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2013 | 120 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2012 | 88 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 76 | 0.020 |
Why?
|
| Cardiology | 1 | 2013 | 120 | 0.020 |
Why?
|
| Ischemia | 1 | 2013 | 253 | 0.020 |
Why?
|
| Cardioplegic Solutions | 1 | 2011 | 17 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 2011 | 17 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2011 | 28 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2012 | 131 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 258 | 0.020 |
Why?
|
| Anesthesiology | 1 | 2013 | 167 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 276 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 231 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2011 | 160 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2013 | 291 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 235 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 493 | 0.020 |
Why?
|
| Anesthesia | 1 | 2011 | 175 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1713 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 688 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 444 | 0.020 |
Why?
|